Continuous vital sign monitoring of acute Lassa fever using wearable biosensor devices in West Africa.

Brady Page^1,2, Raphaëlle Klitting³, Matthias G Pauthner³, Steven Steinhubl³, Stephan Wegerich⁴, Margaret Kaiser⁵, Foday Alhasan⁶, Edwin Konuwa⁶, Veronica Koroma⁶, Ibrahim Sumah⁶, Jenneh Brima⁶, Tiangay Kallon⁶, Brima Jusu⁶, Sia Mator-Mabay⁶, Mohamed Kamara⁶, Fatima Kamara⁶, Emilia Jaward⁶, Angella Massally⁶, Zainab Kanneh⁶, Michelle McGraw³, John Schieffelin⁷, Donald Grant⁶, Kristian G Andersen³

¹University of California, San Diego (UCSD), La Jolla, CA, USA. bpage@ucsd.edu.

²Scripps Research Institute, La Jolla, CA, USA. bpage@ucsd.edu.

³Scripps Research Institute, La Jolla, CA, USA.

⁴Prolaio, Inc, Scottsdale, AZ, USA.

⁵Independent researcher, Greenville, SC, USA.

⁶Kenema Government Hospital, Kenema, Sierra Leone.

⁷Tulane University School of Medicine, New Orleans, LA, USA.

PubMed PMC DOI PDF

Abstract

BACKGROUND: Lassa fever is a fulminant viral illness associated with high in-hospital mortality. This disease constitutes a serious public health concern in West Africa, in particular Nigeria and the Mano River Union region (Guinea, Liberia, and Sierra Leone). In Sierra Leone, continuous monitoring of critically ill patients is hindered by a lack of equipment and personnel. METHODS: We used weara…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.